Crinetics Pharmaceuticals Announces July 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

The 2021 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Crinetics, or following a bona fide period of non-employment, as an inducement material to such individuals' entering into employment with Crinetics, pursuant to Nasdaq Listing Rule 5635(c) (4). The options have an exercise price of $50.80 per share, which is equal to the closing price of Crinetics' common stock on The Nasdaq Global Select Market on July 10, 2024. The shares subjec ...